Abstract Number: VPB1427
Meeting: ISTH 2022 Congress
Background: Anticoagulant thromboprophylaxis with low-molecular-weight heparin (LMWH) for patients with a previous venous thromboembolism (VTE) is recommended. There are only limited cases of its use in the prevention of thrombotic complications in pregnancy.
Aims: The authors present the results of a prospective and longitudinal study of haemostasis in at-risk pregnant patients.
Methods: Blood samples were taken at these time points: T1 during the 10th–12th week of pregnancy (WP), T2 in the 16th–18th WP, T3 between the 26th–28th WP, T4 in the 35th–36th WP and T5 between the 6th–8th week following the delivery.
Results of clotting time (CT), clot formation time (CFT), alpha angle (AA) and maximum clot firmness (MCF) were compared between T1–T4 and T5 when selected parameters are expected to be normalized. The authors also compared the results with the data of the control group.
Written informed consent of included patients was obtained and the study was approved by the Ethics committee of the Jessenius Faculty of Medicine. Study complies with the Declaration of Helsinki. The authors do not have any conflict of interest.
Results: The authors observed shortening of CFT in EXTEM (p 0.0007 from the 26th WP vs. control group) and INTEM (p 0.002 from the 35th WP), increase in AA in EXTEM, INTEM, and HEPTEM, and the persistent increase in MCF in all three mentioned tests. According to the results, LMWH dose was modified in particular patients.
Conclusion(s): Even after the postpartum period, AA in EXTEM was steeper when comparing with the control group (p 0.0007). This may indicate that haemostasis is not completely normalized after 6–8 weeks after delivery.
ROTEM seems to be a helpful tool for the individual assessment of the termination of secondary thromboprophylaxis.
Acknowledgement: The authors thank the support of projects of the Agency for the Support of Research and Development APVV-16-0020 and Scientific Grant Agency 1/0549/19.
To cite this abstract in AMA style:Stanciakova L, Dobrotova M, Holly P, Zolkova J, Vadelova L, Skornova I, Ivankova J, Brunclikova M, Grendar M, Danko J, Kubisz P, Stasko J. The use of rotational thromboelastometry in the management of thromboprophylaxis in pregnancy [abstract]. https://abstracts.isth.org/abstract/the-use-of-rotational-thromboelastometry-in-the-management-of-thromboprophylaxis-in-pregnancy/. Accessed February 27, 2024.
« Back to ISTH 2022 Congress
ISTH Congress Abstracts - https://abstracts.isth.org/abstract/the-use-of-rotational-thromboelastometry-in-the-management-of-thromboprophylaxis-in-pregnancy/